RemedyMD said ComprehensiveBMT solves key challenges of hematopoietic stem cell transplant (HSCT) research such as reporting data obtained from patients and donors (various disparate sources) after aggregating, linking, harmonizing, analyzing and reporting it as necessary to the CIBMTR.
ComprehensiveBMT product manager Matthew Gress said the company worked closely with the CIBMTR when building the forms included with the product, and users will now get the benefit of submitting forms electronically.
RemedyMD president and COO Jim Hyde said they are committed to using their technology platform to stay ahead of the new comprehensive forms as they are released.
Sample organizations using RemedyMD registries include Wisconsin’s Blood Research Institute, Children’s National Medical Center, Oklahoma Medical Research Foundation (OMRF), and several others.